Moreover, the expression level (MFI) of NKG2C on CD57+ NK cells (p = 0.008) was increased in CMV-seropositive MS patients compared to CMV-seronegative MS patients (Figure 2E). This evidence concerns the gene KLRC2 and myeloid sarcoma.